Clinical Trial Update: Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy [NA]

View source ↗

Summary

Clinical trial evaluating Febuxostat for prevention of cerebral and cardiorenovascular events in people with hyperuricemia; trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia

Drugs mentioned

• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Freed Study Group | Conditions: Hyperuricemia | NA | Status: UNKNOWN